Quick Answer
Perspective Therapeutics, Inc. reported Stockholders Equity of $207.03 million for fiscal year 2025.
Perspective Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $207.03M | -28.8% |
| 2024 | $290.67M | +286.6% |
| 2023 | $75.18M | +37.6% |
| 2022 | $54.64M | -10.8% |
| 2022 | $61.28M | -9.1% |
| 2021 | $67.41M | +1077.8% |
| 2020 | $5.72M | -25.5% |
| 2019 | $7.68M | +52.7% |
| 2018 | $5.03M | -52.6% |
| 2017 | $10.60M | -35.4% |
| 2016 | $16.40M | -21.1% |
| 2015 | $20.78M | -13.2% |
| 2014 | $23.96M | +346.4% |
| 2013 | $5.37M | -7.8% |
| 2012 | $5.82M | -9.8% |
| 2011 | $6.45M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $242.22M | -26.3% | -8.8% |
| June 30, 2025 | $265.69M | -22.1% | -6.7% |
| March 31, 2025 | $284.64M | +23.8% | -2.1% |
| December 31, 2024 | $290.67M | +286.6% | -11.5% |
| September 30, 2024 | $328.47M | +232.6% | -3.7% |
| June 30, 2024 | $341.00M | +213.8% | +48.3% |
| March 31, 2024 | $229.89M | +94.8% | +205.8% |
| December 31, 2023 | $75.18M | +37.6% | -23.9% |
- Perspective Therapeutics, Inc. showed a decrease of -28.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, Perspective Therapeutics, Inc.’s stockholders equity has grown by 3108.5% (from $6.45 million to $207.03 million).
- The most recent figure is from Perspective Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: